Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 3, keine Gesamtzahl für „Tevimbra“
Suchtreffer
Begriffe & Kennungen
Tevimbra · 4.8 · Myocarditis occurred in 1.2% of patients treated with tislelizumab in combination with chemotherapy, including
Eintrag öffnenTevimbra · 4.8 · Pneumonitis occurred in 11.2% of patients with NSCLC treated with tislelizumab in combination with chemotherap
Eintrag öffnenTevimbra · 4.8 · Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows con
Eintrag öffnenTevimbra · 4.8 · Summary of the safety profile
Eintrag öffnenTevimbra · 4.8 · Table 2 Adverse reactions with Tevimbra as monotherapy (N = 1952) and in combination with chemotherapy (N = 19
Eintrag öffnenTevimbra · 4.8 · Tabulated list of adverse reactions
Eintrag öffnenTevimbra · 4.8 · The data below reflect information for significant adverse drug reactions for tislelizumab as monotherapy in c
Eintrag öffnenTevimbra · 4.8 · The median time from first dose to onset of the event was 1.5 months (range: 1.0 day to 36.1 months). The medi
Eintrag öffnenTevimbra · 4.8 · The median time from first dose to onset of the event was 1.5 months (range: 15.0 days to 12.1 months). The me
Eintrag öffnenTevimbra · 4.8 · The median time from first dose to onset of the event was 1.5 months (range: 15.0 days to 39.3 months), and th
Eintrag öffnenTevimbra · 4.8 · The median time from first dose to onset of the event was 1.6 months (range: 14.0 days to 33.6 months), and th
Eintrag öffnenTevimbra · 4.8 · The median time from first dose to onset of the event was 10.3 months (range: 1.4 months to 16.9 months). The
Eintrag öffnenTevimbra · 4.8 · The median time from first dose to onset of the event was 2.0 months (range: 14.0 days to 20.7 months). The me
Eintrag öffnenTevimbra · 4.8 · The median time from first dose to onset of the event was 2.1 months (range: 6.0 days to 39.4 months). The med
Eintrag öffnenTevimbra · 4.8 · The median time from first dose to onset of the event was 22.0 days (range: 1.0 day to 4.1 months), and the me
Eintrag öffnenTevimbra · 4.8 · The median time from first dose to onset of the event was 4.0 months (range: 1.0 day to 29.9 months). The medi
Eintrag öffnenTevimbra · 4.8 · The median time from first dose to onset of the event was 4.1 months (range: 1.0 day to 55.0 months), and the
Eintrag öffnenTevimbra · 4.8 · The median time from first dose to onset of the event was 6.0 months (range: 6.0 days to 26.5 months), and the
Eintrag öffnenTevimbra · 4.8 · The median time from first dose to onset of the event was 6.5 months (range: 1.1 months to 36.1 months). The m
Eintrag öffnenTevimbra · 4.8 · The median time from first dose to onset of the event was 9.0 months (range: 22.0 days to 16.2 months). The me
Eintrag öffnen